Currently viewing the category: "Gleevec"

Novartis patent bid rejected in India

By · 1 Comment

An Indian court has rejected Novartis’ challenge of a law that denies patent protection to drugs that are only minor improvements to earlier drugs. Novartis’ challenge came after the Indian government allowed drug companies to make generic versions of the cancer drug Gleevec.

This is great news for consumers — both because it enables [...]

Continue Reading →